As of 2025-06-04, the Intrinsic Value of Vaxil Bio Ltd (VXL.V) is -1.62 CAD. This VXL.V valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.23 CAD, the upside of Vaxil Bio Ltd is -806.12%.
Based on its market price of 0.23 CAD and our intrinsic valuation, Vaxil Bio Ltd (VXL.V) is overvalued by 806.12%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.62 - -1.62 | -1.62 | -806.12% |
| P/E | (0.05) - (0.07) | (0.06) | -125.4% |
| DDM - Stable | (0.72) - (10.67) | (5.70) | -2576.7% |
| DDM - Multi | (0.66) - (7.92) | (1.24) | -637.9% |
| Market Cap (mil) | 0.63 |
| Beta | -0.05 |
| Outstanding shares (mil) | 2.74 |
| Enterprise Value (mil) | 0.18 |
| Market risk premium | 5.10% |
| Cost of Equity | 7.42% |
| Cost of Debt | 5.00% |
| WACC | 5.54% |